{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-21-000106","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2021-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.879989+00:00","generated_at":"2026-06-28T18:21:55.132838+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Exagen refinances $27.2M term loan with Innovatus; maturity extended to Nov 2026","bullets":["$27.2M term loan at 8.0% interest (2% paid in-kind) from Innovatus.","Interest-only period extended through December 2024; maturity extended to November 19, 2026.","Financial covenant revised to revenue-based test starting Q4 2022, with cure options via equity or sub debt.","Effective November 1, 2021; press release issued October 25, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-21-000106","json":"https://secwatch.observer/filing/0001274737-21-000106.json","markdown":"https://secwatch.observer/filing/0001274737-21-000106.md","text":"https://secwatch.observer/filing/0001274737-21-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/0001274737-21-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/exdx-20211021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T18:21:55.132838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}